ArticleMolecular cancer therapeutics2017

CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma.

Chang-Xin Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.